Literature DB >> 11113336

Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities.

T Sabo1, L Lomnitski, A Nyska, S Beni, R R Maronpot, E Shohami, A D Roses, D M Michaelson.   

Abstract

Apolipoprotein E, the major brain lipid-binding protein, is expressed in humans as three common isoforms (E2, E3 and E4). Previous studies revealed that the allele apolipoprotein E4 is a major genetic risk factor of Alzheimer's disease and that traumatic brain injury is associated with increased risk for developing this disease. Furthermore, it has been suggested that the effects of traumatic head injury and apolipoprotein E4 in Alzheimer's disease are synergistic. To test the hypothesis that the apolipoprotein E genotype affects susceptibility to brain injury, we subjected transgenic mice, expressing either human apolipoprotein E3 or human apolipoprotein E4 on a null mouse apolipoprotein E background and apolipoprotein E-deficient knockouts, to closed head injury and compared mortality, neurological recovery and the extent of brain damage of the survivors. More than 50% of the transgenic mice expressing human apolipoprotein E4 died following closed head injury, whereas only half as many of the transgenic mice expressing human apolipoprotein E3, and of the control and apolipoprotein E-deficient mice died during this period (P<0.02). A neurological severity score used for clinical assessment of the surviving mice up to 11 days after closed head injury revealed that the four mouse groups displayed similar severity of damage at 1h following injury. At three and 11 days post-injury, however, the neurological severity scores of the transgenic mice expressing human apolipoprotein E3 were significantly lower than those of the other three groups whose scores were similar, indicating better recovery of the transgenic mice expressing human apolipoprotein E3. Histopathological examination of the mice performed 11 days post-injury revealed, consistent with the above neurological results, that the size of the damaged brain area of the transgenic mice expressing human apolipoprotein E3 was smaller than that of the other head-injured groups. These findings show that transgenic mice expressing human apolipoprotein E4 are more susceptible than those expressing apolipoprotein E3 to closed head injury. We suggest that this effect is due to both a protective effect of apolipoprotein E3 and an apolipoprotein E4-related pathological function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113336     DOI: 10.1016/s0306-4522(00)00438-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  34 in total

Review 1.  Candidate mechanisms for chemotherapy-induced cognitive changes.

Authors:  Tim A Ahles; Andrew J Saykin
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

Review 2.  Genetic influences on outcome following traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

3.  A high cholesterol diet given to apolipoprotein E-knockout mice has a differential effect on the various neurotrophin systems in the hippocampus.

Authors:  Zhi-Yu Wang; Takanori Miki; Yan Ding; Shi-Jie Wang; Yu-Huan Gao; Xiao-Ling Wang; Yu-Hua Wang; Toshifumi Yokoyama; Katsuhiko Warita; Ken-ichi Ohta; Shingo Suzuki; Taira Ohnishi; Takashi Obama; Kuldip S Bedi; Yoshiki Takeuchi; Bao-En Shan
Journal:  Metab Brain Dis       Date:  2011-08-09       Impact factor: 3.584

Review 4.  Beta-amyloid and cholinergic neurons.

Authors:  Vladimír Dolezal; Jana Kasparová
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

5.  Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice.

Authors:  Sean S Davies; Chris Bodine; Elena Matafonova; Brooke G Pantazides; Nathalie Bernoud-Hubac; Fiona E Harrison; Sandra J Olson; Thomas J Montine; Venkataraman Amarnath; L Jackson Roberts
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice.

Authors:  Rachel E Bennett; Thomas J Esparza; Hal A Lewis; Eddie Kim; Christine L Mac Donald; Patrick M Sullivan; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

Review 7.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

Review 8.  Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.

Authors:  Thomas W McAllister; Tim A Ahles; Andrew J Saykin; Robert J Ferguson; Brenna C McDonald; Lionel D Lewis; Laura A Flashman; C Harker Rhodes
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

Review 9.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.

Authors:  N Nathoo; R Chetty; J R van Dellen; G H Barnett
Journal:  Mol Pathol       Date:  2003-06

10.  A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage.

Authors:  Junling Gao; Haichen Wang; Huaxin Sheng; John R Lynch; David S Warner; Lori Durham; Michael P Vitek; Daniel T Laskowitz
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.